Holen Sie sich die Stockscreener-App
11.98
12.11%
-1.65
Handel nachbörslich:
12.04
0.06
+0.50%
Schlusskurs vom Vortag:
$13.63
Offen:
$13.57
24-Stunden-Volumen:
5.28M
Relative Volume:
4.80
Marktkapitalisierung:
$882.50M
Einnahmen:
$193.35M
Nettoeinkommen (Verlust:
$-177.58M
KGV:
-4.8898
EPS:
-2.45
Netto-Cashflow:
$-172.43M
1W Leistung:
-10.33%
1M Leistung:
-34.86%
6M Leistung:
-35.70%
1J Leistung:
-51.08%
1-Tages-Spanne:
$11.79
$13.74
1-Wochen-Bereich:
$11.79
$13.94
52-Wochen-Spanne:
$11.79
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
11.98 | 1.00B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrodinger stock hits 52-week low at 12.8 USD By Investing.com - Investing.com Nigeria
Schrodinger (NASDAQ:SDGR) Insider Sells $16,617.30 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Reaches New 12-Month LowWhat's Next? - MarketBeat
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - PharmiWeb.com
Schrodinger stock hits 52-week low at 12.8 USD - Investing.com
Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Trading Systems Reacting to (SDGR) Volatility - Stock Traders Daily
With A 26% Price Drop For Schrödinger, Inc. (NASDAQ:SDGR) You'll Still Get What You Pay For - simplywall.st
Schrodinger stock hits 52-week low at 13.43 USD By Investing.com - Investing.com Nigeria
Schrodinger (NASDAQ:SDGR) Hits New 12-Month LowShould You Sell? - MarketBeat
Schrodinger stock hits 52-week low at 13.43 USD - Investing.com
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth - DirectorsTalk Interviews
TruBridge (TBRG) Surges 5.6%: Is This an Indication of Further Gains? - Nasdaq
Analysts Are Bullish on Top Healthcare Stocks: Spectral AI (MDAI), Schrodinger (SDGR) - The Globe and Mail
Schrodinger (NASDAQ:SDGR) Upgraded at Wall Street Zen - MarketBeat
Is Schrödinger Inc. stock a good dividend stock2025 Historical Comparison & Weekly Stock Performance Updates - mfd.ru
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 60.98% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Schrodinger Inc stock hits 52-week low at $15.97 By Investing.com - Investing.com Nigeria
Schrodinger Inc stock hits 52-week low at $15.97 - Investing.com
How Schrodinger Inc. (SDGR) Affects Rotational Strategy Timing - Stock Traders Daily
Massachusetts Financial Services Co. MA Acquires 577,899 Shares of Schrodinger, Inc. $SDGR - MarketBeat
86,319 Shares in Schrodinger, Inc. $SDGR Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ:SDGR) Shares Down 5.2%Time to Sell? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $91.37 Million Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
(SDGR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Schrödinger Inc. stock could be next big winnerMarket Performance Report & Low Risk Entry Point Guides - Bộ Nội Vụ
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities By Investing.com - Investing.com South Africa
Assessing Schrödinger (SDGR) Valuation After Recent Uneven Share Price Momentum - Yahoo Finance
Schrödinger partners with Lilly TuneLab on AI drug discovery - Drug Target Review
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities - Investing.com Australia
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - BioSpace
Schrödinger outlines 2026 priorities after strong 2025 By Investing.com - Investing.com Nigeria
Schrödinger outlines 2026 priorities after strong 2025 - Investing.com
Manas AI Secures Strategic Advantage through Unique Deep Integration with Schrödinger’s Physics + AI Discovery Platform - 01net
Schrodinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Chemoinformatics Market to Reach US$ 24.43 Billion by 2033 | CAGR - openPR.com
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software - WKZO
Will Schrödinger Inc. stock benefit from automation2025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
Schrodinger (NASDAQ:SDGR) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Schrödinger partners with Lilly TuneLab to enhance drug discovery By Investing.com - Investing.com Nigeria
Schrödinger, Inc.'s (NASDAQ:SDGR) Earnings Haven't Escaped The Attention Of Investors - 富途牛牛
Is Schrödinger’s TuneLab AI Integration Reshaping the Investment Case For SDGR? - simplywall.st
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign - pharmiweb.com
Schrödinger (SDGR) Partners with Eli Lilly for AI-Driven Drug Di - GuruFocus
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software - Reuters
Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery - MSN
Schrödinger (SDGR) Partners with Eli Lilly for AI Drug Discovery - GuruFocus
Eli Lilly in pact with Schrödinger in AI-related drug discovery - Seeking Alpha
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):